Last reviewed · How we verify

COVID-19 Vaccine,Inactivated — Competitive Intelligence Brief

COVID-19 Vaccine,Inactivated (COVID-19 Vaccine,Inactivated) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Inactivated viral vaccine. Area: Immunology.

phase 3 Inactivated viral vaccine Immunology Biologic Live · refreshed every 30 min

Target snapshot

COVID-19 Vaccine,Inactivated (COVID-19 Vaccine,Inactivated) — Sinovac Research and Development Co., Ltd.. An inactivated viral vaccine that stimulates the immune system to produce antibodies and cellular immunity against SARS-CoV-2 by presenting inactivated virus particles.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
COVID-19 Vaccine,Inactivated TARGET COVID-19 Vaccine,Inactivated Sinovac Research and Development Co., Ltd. phase 3 Inactivated viral vaccine
Havrix 720 Junior Havrix 720 Junior Chiang Mai University marketed Inactivated viral vaccine Hepatitis A virus surface antigen
fIPV (0.1mL) IM fIPV (0.1mL) IM Centers for Disease Control and Prevention marketed inactivated viral vaccine poliovirus serotypes 1, 2, and 3
Hepatitis A (control) Hepatitis A (control) International Vaccine Institute marketed inactivated viral vaccine Hepatitis A virus surface antigens
IPV at 6 weeks of age IPV at 6 weeks of age Centers for Disease Control and Prevention marketed Inactivated viral vaccine Poliovirus types 1, 2, and 3
EV71 inactived vaccine（Vero cells） EV71 inactived vaccine（Vero cells） Sinovac Biotech Co., Ltd marketed inactivated viral vaccine Enterovirus 71 (EV71) viral antigens
Hepatitis A vaccine Hepatitis A vaccine MacroGenics marketed inactivated viral vaccine Hepatitis A virus surface antigens

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Inactivated viral vaccine class)

  1. Sinovac Biotech Co., Ltd · 9 drugs in this class
  2. Sanofi Pasteur, a Sanofi Company · 9 drugs in this class
  3. GlaxoSmithKline · 5 drugs in this class
  4. Valneva Austria GmbH · 4 drugs in this class
  5. Medical University of Vienna · 3 drugs in this class
  6. Centers for Disease Control and Prevention · 3 drugs in this class
  7. China National Biotec Group Company Limited · 2 drugs in this class
  8. Statens Serum Institut · 2 drugs in this class
  9. Institute of Medical Biology, Chinese Academy of Medical Sciences · 2 drugs in this class
  10. Crucell Holland BV · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). COVID-19 Vaccine,Inactivated — Competitive Intelligence Brief. https://druglandscape.com/ci/covid-19-vaccine-inactivated. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators: